A61K 49/228
Host-guest complexes, clathrates, chelates
Official title: {Host-guest complexes, clathrates, chelates}
A61K49/228 (Host-guest complexes, clathrates, chelates) appears on 10 US grants and 3 published applications in this corpus.
Search patents in A61K- Granted patents
- 10
- Published applications
- 3
- Assignees
- 7
- Inventors
- 27
- Latest grant
- 12 Feb 2008
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1995 | 1 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 2 | 0 |
| 2001 | 3 | 0 |
| 2002 | 0 | 0 |
| 2003 | 1 | 1 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 1 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 1 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 0 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Methods of imaging and treatment12 Feb 2008US 7,329,402 B2ImaRx Pharmaceutical Corp.
- Methods of imaging and treatment with targeted compositions18 Feb 2003US 6,521,211 B1Bristol-Myers Squibb Medical Imaging, Inc.
- Ultrasonic contrast agents, process for their preparation and their use as a diagnostic and therapeutic agent24 Jul 2001US 6,264,959 B1Schering Corporation
- Methods for ultrasound imaging involving the use of a contrast agent and multiple images and processing of same15 May 2001US 6,231,834 B1ImaRx Pharmaceutical Corp.
- Agents and methods for enhancing contrast in ultrasound imaging23 Jan 2001US 6,177,062 B1Schering Corporation
- Metal composite for ultrasonic contrast and use thereof10 Jul 2025US 2025/0222142 A1Original Biomedicals Co., Ltd
- Inclusion complexes suitable for use as a histotripsy agent7 Jan 2021US 2021/0000986 A1T.C Istanbul Medipol üNiversitesi
- Novel methods of imaging and treatment with targeted compositions21 Aug 2003US 2003/0157025 A1ImaRx Pharmaceutical Corp.
Most cited
By later US patents
- Ultrasonic contrast agents for color Doppler imaging292US 5,425,366 ASchering Corporation · 1995
- Methods of imaging and treatment with targeted compositions168US 6,521,211 B1Bristol-Myers Squibb Medical Imaging, Inc. · 2003
- Targeted contrast agents for diagnostic and therapeutic use163US 6,139,819 AImaRx Pharmaceutical Corp. · 2000
- Methods for ultrasound imaging involving the use of a contrast agent and multiple images and processing of same159US 6,231,834 B1ImaRx Pharmaceutical Corp. · 2001
- Use of fullerenes in diagnostic and/or therapeutic agents95US 5,688,486 ANycomed Salutar, Inc. · 1997